-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

From Science Fiction to Standard of Care: Developing the next wave of Genomic Medicines for Hematology

Sponsor: Cytiva
Program: Industry Theaters
Monday, December 12, 2022: 12:15 PM-1:15 PM
Hall J - Theater 6 (Ernest N. Morial Convention Center)
Sadik Kassim, PhD, Danaher Genomic Medicine
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Industry Theaters